Genetic Technologies (GENE)

Add to Watchlists
Create an Alert
1.34 +0.02  +1.52% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
GENE Price Chart
View All Events

GENE Events

Date Type Description
Nov 29 Misc AGM Event for Genetic Technologies Ltd.
Oct 23 Misc EGM Event for Genetic Technologies Ltd.
View All Performance Charts

GENE Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Genetic Technologies is down 51.27% over the last year vs S&P 500 Total Return up 22.52%, Bio-Reference Labs up 16.16%, and Agilent Technologies up 25.93%.

Get Quote for

Portfolio Strategies Featuring GENE

Did Genetic Technologies make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GENE Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: Australia
  • Headquarters State/Province: N/A
  • Incorporation Country: Australia
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Genetic Technologies Limited is a biotechnology company. It provides genetic testing services. It also conducts out-licensing of its intellectual property relating to non-coding DNA and research and development in the areas of genetics and related fields.

Recent Quotes

Symbol Price Chg Chg % Market Cap
GENE 1.34 +0.02 +1.52% 25.97M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.